Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Endocrinology
|
August 4, 2007
Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells
Nicole A Sherry, Wei Chen, Jake A Kushner, et al.
Diabetes Care
|
June 26, 2018
HbA<sub>1c</sub> and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
Thomas Danne, Bertrand Cariou, Phillip Banks, et al.
Diabetes Care
|
March 6, 2019
Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program
Thomas Danne, Bertrand Cariou, John B Buse, et al.
Plos One
|
July 14, 2016
Resolving Discrepant Findings on ANGPTL8 in β-Cell Proliferation: A Collaborative Approach to Resolving the Betatrophin Controversy
Aaron R Cox, Ornella Barrandon, Erica P Cai, et al.
Diabetes Care
|
September 15, 2020
Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies
Anne L Peters, Darren K McGuire, Thomas Danne, et al.
The Journal of Clinical Investigation
|
May 8, 2002
Pdx1 restores beta cell function in Irs2 knockout mice
Jake A Kushner, Jing Ye, Markus Schubert, et al.
Molecular Endocrinology (Baltimore, Md.)
|
November 29, 2013
GATA factors promote ER integrity and β-cell survival and contribute to type 1 diabetes risk
Daniel J Sartori, Christopher J Wilbur, Simon Y Long, et al.
Diabetes, Obesity & Metabolism
|
July 3, 2019
Dose-dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial
Claire Baker, Suman Wason, Phillip Banks, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 9, 2003
Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation
Markus Schubert, Derek P Brazil, Deborah J Burks, et al.
Molecular Cell
|
October 2, 2012
miR-211 is a prosurvival microRNA that regulates chop expression in a PERK-dependent manner
Nilesh S Chitnis, Dariusz Pytel, Ekaterina Bobrovnikova-Marjon, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Endocrinology
|
August 4, 2007
Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells
Nicole A Sherry, Wei Chen, Jake A Kushner, et al.
Diabetes Care
|
June 26, 2018
HbA<sub>1c</sub> and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
Thomas Danne, Bertrand Cariou, Phillip Banks, et al.
Diabetes Care
|
March 6, 2019
Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program
Thomas Danne, Bertrand Cariou, John B Buse, et al.
Plos One
|
July 14, 2016
Resolving Discrepant Findings on ANGPTL8 in β-Cell Proliferation: A Collaborative Approach to Resolving the Betatrophin Controversy
Aaron R Cox, Ornella Barrandon, Erica P Cai, et al.
Diabetes Care
|
September 15, 2020
Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies
Anne L Peters, Darren K McGuire, Thomas Danne, et al.
The Journal of Clinical Investigation
|
May 8, 2002
Pdx1 restores beta cell function in Irs2 knockout mice
Jake A Kushner, Jing Ye, Markus Schubert, et al.
Molecular Endocrinology (Baltimore, Md.)
|
November 29, 2013
GATA factors promote ER integrity and β-cell survival and contribute to type 1 diabetes risk
Daniel J Sartori, Christopher J Wilbur, Simon Y Long, et al.
Diabetes, Obesity & Metabolism
|
July 3, 2019
Dose-dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial
Claire Baker, Suman Wason, Phillip Banks, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 9, 2003
Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation
Markus Schubert, Derek P Brazil, Deborah J Burks, et al.
Molecular Cell
|
October 2, 2012
miR-211 is a prosurvival microRNA that regulates chop expression in a PERK-dependent manner
Nilesh S Chitnis, Dariusz Pytel, Ekaterina Bobrovnikova-Marjon, et al.
Page
of 7